SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Raises Price Target to $5

HC Wainwright & Co. reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and raises the price target from $2.5 to $5.

Benzinga · 05/19/2020 11:03

HC Wainwright & Co. reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and raises the price target from $2.5 to $5.